Axsome Therapeutics Inc.
AXSMUnited States
43 filed reports · 393 financial concepts · 0 earnings calls · 0 media appearances
Filed reports
43 reports · Mar 2016 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 31 | 4,163 | Jun 2016 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 10 | 3,264 | Dec 2016 to Dec 2025 |
| Quarterly · 10-Q/ASEC EDGAR | 2 | 79 | Mar 2016 to Sep 2020 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 10, 2026 | 391 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 4, 2026 | 254 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 23, 2026 | 789 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 3, 2025 | 261 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 4, 2025 | 173 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 5, 2025 | 186 | Open |
| FY2024 | 10-K | Dec 31, 2024 | Feb 18, 2025 | 393 | Open |
| FY2024 Q3 | 10-Q | Sep 30, 2024 | Nov 12, 2024 | 181 | Open |
| FY2024 Q2 | 10-Q | Jun 30, 2024 | Aug 5, 2024 | 164 | Open |
| FY2024 Q1 | 10-Q | Mar 31, 2024 | May 6, 2024 | 175 | Open |
| FY2023 | 10-K | Dec 31, 2023 | Feb 23, 2024 | 327 | Open |
| FY2023 Q3 | 10-Q | Sep 30, 2023 | Nov 6, 2023 | 167 | Open |
Financial data
393 concepts · 7,506 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial388 concepts · 7,387 facts · Dec 2014 to Jun 2026
- Allocated share based compensation expense58 · Dec 2014 to Jun 2026
- Common stock shares authorized58 · Dec 2014 to Jun 2026
- Increase decrease in accounts payable58 · Dec 2014 to Jun 2026
- Investment income net58 · Dec 2014 to Jun 2026
- Net cash provided by used in operating activities58 · Dec 2014 to Jun 2026
- Net income loss58 · Dec 2014 to Jun 2026
- Operating income loss58 · Dec 2014 to Jun 2026
- Prepaid expenses and other current assets58 · Dec 2014 to Jun 2026
- Research and development expense58 · Dec 2014 to Jun 2026
- Share based compensation58 · Dec 2014 to Jun 2026
- Class of warrant or right outstanding57 · Dec 2014 to Jun 2026
- Common stock par or stated value per share57 · Dec 2014 to Jun 2026
- Depreciation57 · Mar 2015 to Jun 2026
- Share based compensation arrangement by share based payment award options outstanding number57 · Dec 2014 to Jun 2026
- Share based compensation arrangement by share based payment award options outstanding weighted average exercise price57 · Dec 2014 to Jun 2026
- Stockholders equity (US GAAP)57 · Dec 2014 to Jun 2026
- Accounts payable current55 · Dec 2015 to Jun 2026
- Assets55 · Dec 2015 to Jun 2026
- Assets current55 · Dec 2015 to Jun 2026
- Common stock shares issued55 · Dec 2015 to Jun 2026
- Common stock shares outstanding55 · Dec 2015 to Jun 2026
- Common stock value55 · Dec 2015 to Jun 2026
- Employee related liabilities current55 · Dec 2015 to Jun 2026
- Liabilities and stockholders equity55 · Dec 2015 to Jun 2026
Product4 concepts · 116 facts · Mar 2022 to Jun 2026
- Revenue111 · Jun 2022 to Jun 2026
- Cost of revenue (US GAAP)2 · Mar 2023 to Jun 2023
- Revenue (excluding assessed tax)2 · Mar 2025 to Mar 2026
- Cost of Revenue1 · Mar 2022
Geography1 concepts · 3 facts · Dec 2022 to Jun 2023
- Revenue3 · Dec 2022 to Jun 2023
Segments
119 factsFigures broken down by business line, region, product or another axis the company reports on.
Product or service6 members · 116 facts
- Product59 · Jun 2022 to Jun 2026
- Royalty22 · Mar 2023 to Sep 2025
- Royalty And Milestone Revenue17 · Dec 2022 to Jun 2026
- License15 · Dec 2022 to Dec 2025
- Royalty2 · Mar 2025 to Mar 2026
- License1 · Mar 2022
Statement geographical1 member · 3 facts
- Non Us3 · Dec 2022 to Jun 2023
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary115 claims from 10 reports · Sep 2024 to Jun 2026
- Management discussion (MD&A) commentary121 claims from 8 reports · Sep 2024 to Jun 2026
- Risk-factor changes12 claims from 1 reports · Dec 2025
- Risk factors135 risks from 2 annual reports · 2024 to 2025
Earnings calls
Transcripts with management claims and analyst questions, one per fiscal period.
No earnings-call transcripts for this company.
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.